Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study (Q42681472)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2005
edit
Language Label Description Also known as
English
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study
scientific article published on December 2005

    Statements

    Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study (English)
    Jonathan M Meyer
    Gahan Pandina
    Cynthia A Bossie
    Ibrahim Turkoz
    Andrew Greenspan
    1 December 2005
    1930-1941

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit